Christopher Rovaldi, COO of Keros Therapeutics KROS, has filed 3 transactions, none an open-market purchase or sale. The latest trade was on 25/02/18.

Christopher Rovaldi

COO

Company: Keros Therapeutics KROS
First filing: 23/02/17

Trades: 3 trades
Buys / sales: 0 / 0
12-month net buying: No record
Last trade: 25/02/18

Trading activity

Transactions

No filed transactions.